Advertisement

Estrogen and Progesterone Receptors as Prognostic Factors in Early Breast Cancer

  • S. Saez
  • F. Cheix
  • M. Mayer
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 91)

Abstract

During the past 10 years, steroid receptors in human breast tumors have been extensively investigated in many laboratories. The initial aim of this clinical research was to help in selecting patients with metastasis for hormonal treatment.

Keywords

Estrogen Receptor Progesterone Receptor Axillary Node Axillary Node Status Positive Axillary Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allegra JC, Lippman ME, Thompson EB, Simon A, Barlock A, Green L, Huff KK, Do HM, Aitken SC (1979) Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 39: 1447–1454PubMedGoogle Scholar
  2. 2.
    Dao TL, Nemoto T (1980) Steroid receptors and response to endocrine ablation in women with metastatic cancer of the breast. Cancer 46: 2779–2782PubMedCrossRefGoogle Scholar
  3. 3.
    Hilf R, Feldstein ML, Gibson SL, Savlon ED (1980) The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer 45: 1993–2000PubMedCrossRefGoogle Scholar
  4. 4.
    Horwitz K, McGuire WL (1978) Estrogen control of progesterone receptors in human breast cancer. J Biol Chem 253: 2273–2278Google Scholar
  5. 5.
    Huggins L, Grand CC, Brillantes PP (1961) Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature 189: 204–207PubMedCrossRefGoogle Scholar
  6. 6.
    Jensen EV, Block GF, Smith S, Kyser K, DeSombre ER (1971) Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr 34: 55–70PubMedGoogle Scholar
  7. 7.
    Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671PubMedGoogle Scholar
  8. 8.
    Meyer JS, Hixon B (1979) Advanced stage and early relapse of breast adenocarcinoma associated with high thymidine labeling indices. Cancer Res 39: 4042–4047PubMedGoogle Scholar
  9. 9.
    McGuire WL (1980) Steroid hormone receptors in breast cancer treatment strategy. Recent Prog Horm Res 36: 135–156PubMedGoogle Scholar
  10. 10.
    McGuire WL, Pearson OH, Segaloff A (1975) Predicting hormone responsiveness in human breast cancer. In: McGuire WL, Carbone PP, Vollmer EP (eds) Estrogen receptors in human breast cancer. Raven, New York, pp 17–30Google Scholar
  11. 11.
    Nomura Y, Yadagata J, Takenaka K, Tashiro H (1980) Steroid hormone receptors and clinical usefulness in human breast cancer. Cancer 46: 2880–2883PubMedCrossRefGoogle Scholar
  12. 12.
    Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II analysis and exemples. Br J Cancer 35: 1–39Google Scholar
  13. 13.
    Pichón MF, Pallud C, Brunet M, Milgrom E (1980) Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 40: 3357–3360PubMedGoogle Scholar
  14. 14.
    Saez S, Chouvet C, Mayer M, Cheix F (1980) Estradiol and progesterone receptor (ER, PGR) as prognostic factors in human primary breast tumors. Proceedings AACR — 553. Cancer Res 21: 139Google Scholar
  15. 15.
    Saez S, Martin PM, Chouvet CD (1978) Estradiol and progesterone receptor in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer 38: 3468–3473Google Scholar
  16. 16.
    Skinner LG, Barnes DM, Ribeiro GG (1980) The clinical value of multiple steroid receptor assays in breast cancer management. Cancer 46: 2939–2945PubMedCrossRefGoogle Scholar
  17. 17.
    Stoll BA (1969) Hormone management in breast cancer. Pittman Medical, London, pp 68–73Google Scholar
  18. 18.
    Union Internationale contre le Cancer (1979) Breast. In: UICC (ed) TNM classification of malignant tumors, pp 47–53Google Scholar
  19. 19.
    Walt AJ, Singhakowinta A, Brooks SC, Cartez A (1976) The surgical implications of estrophile proteins estimations in carcinoma of the breast. Surgery 80: 506–512PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1984

Authors and Affiliations

  • S. Saez
    • 1
  • F. Cheix
    • 1
  • M. Mayer
    • 1
  1. 1.Centre Leon BerardLyon, Cedex 8France

Personalised recommendations